TSX closed
Loading markets…
Stocks/TSX-V/MIR

MedMira Inc (MIR : TSX-V)

Common Stock

$0.05

CAD

-0.00 (-9.09%)

Last updated: 2026-11-05

Follow MIR

MIR

MedMira Inc

Source:WealthAwesomeWealthAwesome
↓ $0.02 (-28.57%)
30 day period
$0.05$0.06$0.07Sep 8Oct 8Nov 5

Performance

1 Day

+0.00%

1 Week

+10.00%

1 Month

-8.33%

YTD

-15.38%

Key Statistics

Market Cap

$35.09M

52W High

$0.08

52W Low

$0.05

P/E Ratio

-

50 Day MA

$0.07

200 Day MA

$0.07

Beta

0.87

Dividend Yield

-

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↓Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
11/5/2026$0.05$0.05$0.05$0.05$0.0510,000
11/4/2026$0.06$0.06$0.05$0.06$0.0654,500
11/3/2026$0.06$0.06$0.06$0.06$0.0623,125
11/2/2026$0.05$0.05$0.05$0.05$0.054,400
10/27/2026$0.05$0.05$0.05$0.05$0.0541,270
10/26/2026$0.06$0.06$0.05$0.05$0.05170,658
10/23/2026$0.06$0.06$0.06$0.06$0.0664,125
10/22/2026$0.06$0.06$0.06$0.06$0.064,000
10/20/2026$0.06$0.07$0.06$0.07$0.07223,000
10/19/2026$0.06$0.06$0.06$0.06$0.0610,000

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on MIR's historical volatility

HistoricalForecast68%95%
C$0.01C$0.04C$0.07C$0.10C$0.13C$0.17TodayMay 26Aug 10Nov 5Dec 18Jan 31Mar 15

30-Day Vol

112.8%

Annualized

90-Day Vol

106.6%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$0.04

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.05C$0.03 – C$0.07
60 trading daysC$0.04C$0.03 – C$0.08
90 trading daysC$0.04C$0.02 – C$0.08

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About MedMira Inc

MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.

Financials

Revenue (TTM)
$370,568
EBITDA
$-1.94M
Profit Margin
0.00%
ROE (TTM)
0.00%
EPS (Diluted)
0.00
Book Value
-0.04

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Common Questions About MIR

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
SURF-UNStarlight U.S. Residential Fund (Multi-Family) Investment LP$0.04+100.00%
CBAChampion Bear Resources Ltd.$0.05+66.67%
ABCAbsolutely Critical Resources Corp.$0.01+50.00%
ILIImagine Lithium Inc$0.01+50.00%
FMMFull Metal Minerals Ltd$0.02+33.33%
MGGMinaurum Silver Inc.$0.25+29.49%
EVNIEV Nickel Inc$0.10+25.00%
GRDGrounded Lithium Corp.$0.03+25.00%

MIR.V news timeline

15 articles covering MIR.V, most recent first

Latest

What's Going On With MedMira Inc Stock Wednesday?

•Stocks